Randomised trial of software algorithm-driven regional citrate anticoagulation versus heparin in continuous renal replacement therapy: The filter life in renal replacement therapy pilot trial

Critical Care and Resuscitation

Volumn 16, Issue 2, 2014, Pages 131-137

  Brain, Matthew J ^a,b,c   Roodenburg, Owen S ^c   Adams, Natalie ^c   McCracken, Phoebe ^c   Hockings, Lisen ^c   Musgrave, Steve ^c   Butt, Warwick ^c   Scheinkestel, Carlos ^c  

^a MONASH UNIVERSITY   (Australia)

^b LAUNCESTON GENERAL HOSPITAL   (Australia)

^c Department of Intensive Care and Hyperbaric Medicine The Alfred ^*  (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; SODIUM CHLORIDE;

ACUTE KIDNEY FAILURE; AGED; ALGORITHM; ARTICLE; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EQUIPMENT; FEMALE; FILTRATION; HUMAN; INTENTION TO TREAT ANALYSIS; MALE; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; STATISTICS;

ACUTE KIDNEY INJURY; AGED; ALGORITHMS; ANTICOAGULANTS; FEMALE; FILTRATION; HEPARIN; HUMANS; INTENTION TO TREAT ANALYSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL REPLACEMENT THERAPY; SODIUM CHLORIDE; SOFTWARE;

EID: 84903784862     PISSN: 14412772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Uchino S, Fealy N, Baldwin I, et al. Continuous is not continuous: the incidence and impact of circuit “down-time” on uraemic control during continuous veno-venous haemofiltration. Intensive Care Med 2003; 29: 575-8.
2. Bellomo R, Ronco C. Continuous haemofiltration in the intensive care unit. Crit Care 2000; 4: 339-45.
3. Joannidis M, Oudemans-van Straaten HM. Clinical review: patency of the circuit in continuous renal replacement therapy. Crit Care 2007; 11: 218.
4. Hetzel GR, Schmitz M, Wissing H, et al. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant 2011; 26: 232-9.
5. Oudemans-van Straaten HM, Bosman RJ, Koopmans M, et al. Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 2009; 37: 545-52.
6. Oudemans-van Straaten HM, Kellum JA, Bellomo R. Clinical review: anticoagulation for continuous renal replacement therapy - heparin or citrate? Crit Care 2011; 15: 202.
7. Kleger GR, Fässler E. Can circuit lifetime be a quality indicator in continuous renal replacement therapy in the critically ill? Int J Artif Organs 2010; 33: 139-46.
8. Morgera S. Survival benefit with regional anticoagulation with citrate in CRRT: the end of a myth? Nephrol Dial Transplant 2011; 26: 9-11.
9. Monchi M, Berghmans D, Ledoux D, et al. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 2004; 30: 260-5.
10. Cointault O, Kamar N, Bories P, et al. Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions. Nephrol Dial Transplant 2004; 19: 171-8.
11. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009; 361: 1627-38.
12. Brain M, Parkes S, Fowler P, et al. Calcium flux in continuous venovenous haemodiafiltration with heparin and citrate anticoagulation. Crit Care Resusc 2011; 13: 72-81.
13. R Development Core Team. R: A language and environment for statistical computing [Internet]. Vienna, Austria: 2013. http://www.R-project.org (accessed Mar 2014).
14. Therneau T. A package for survival analysis in S. R package version 2.37-7. 2014. http://CRAN.R-project.org/package=survival (accessed Mar 2014).
15. Wickham H. ggplot2: elegant graphics for data analysis. New York: Springer, 2009.
16. Therneau T. Coxme: Mixed effects Cox models. version 2.2-3. 2012. http://CRAN.R-project.org/package=coxme (accessed Mar 2014).
17. Therneau T. Mixed effects Cox models. http://ftp5.us.postgresql.org/pub/CRAN/web/packages/coxme/vignettes/coxme.pdf (accessed Nov 2013).
18. Bagshaw SM, Laupland KB, Boiteau PJE, Godinez-Luna T. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system. J Crit Care 2005; 20: 155-61.
19. Gambro Lundia AB, Monitor Division Sweden. Prismaflex operator’s manual version 3.xx. 2006.
20. Oudemans-van Straaten HM, Bosman RJ, Koopmans M, et al. Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 2009; 37: 545-52.
21. Hetzel GR, Schmitz M, Wissing H, et al. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant 2011; 26: 232-9.
22. Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000; 356: 26-30.
23. Meier P, Meier R, Turini P, et al. Prolonged catheter survival in patients with acute kidney injury on continuous renal replacement therapy using a less thrombogenic micropatterned polymer modification. Nephrol Dial Transplant 2010; 26: 628-35.